Shanghai Yujun Biological Technology Development Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 38,000,000 on November 26, 2021. The transaction will include participation from new investor Zhejiang Starry Pharmaceutical Co.,Ltd. for a 9.0909% stake holding in the company. The transaction has been approved in the eighteenth resolution of the fourth board of directors of the investor.

Post the transaction, out of CNY 38,000,000, CNY 555,559 will be added to the registered capital of the company and the registered capital of the company will increase from CNY 5,555,600 to CNY 6,111,159.